P838: PEGCETACOPLAN RAPIDLY STABILIZES COMPLEMENT INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA EXPERIENCING HEMOLYSIS WITH ACUTE HEMOGLOBIN DECREASES; PRINCE TRIAL POST HOC ANALYSIS

• R. Wong,
• M. Al-Adhami,
• J. Savage,
• R. Horneff,
• M. Yeh,
• T. Dumagay,
• D. Gomez-Almaguer

Affiliations

R. Wong

1 Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong

M. Al-Adhami

2 Apellis Pharmaceuticals, Inc., Waltham, United States of America

J. Savage

2 Apellis Pharmaceuticals, Inc., Waltham, United States of America

R. Horneff

3 Swedish Orphan Biovitrum AB, Stockholm, Sweden

M. Yeh

4 Apellis Pharmaceuticals, Waltham, Waltham, United States of America

T. Dumagay

5 Department of Cellular Therapeutics, Makati Medical Centre, Makati, Philippines

D. Gomez-Almaguer

6 Hematology Service, Hospital Universitario “Dr José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico